Apeloa Pharmaceutical Co Ltd (000739) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.070x

Based on the latest financial reports, Apeloa Pharmaceutical Co Ltd (000739) has a cash flow conversion efficiency ratio of 0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.18 Million ≈ $65.29 Million USD) by net assets (CN¥6.35 Billion ≈ $928.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000739 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Apeloa Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Apeloa Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Apeloa Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apeloa Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Anhui Expressway Co Ltd
SHG:600012
0.072x
Momentum Metropolitan Holdings Ltd
JSE:MTM
0.051x
Aura Minerals Inc
TO:ORA
0.571x
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
0.051x
Hypera S.A
SA:HYPE3
0.014x
Xuzhou Handler Special Vehicle Co Ltd
SHE:300201
0.029x
ATS CORP
TO:ATS
0.064x
ChengDu Hi-Tech Development Co Ltd
SHE:000628
0.041x

Annual Cash Flow Conversion Efficiency for Apeloa Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Apeloa Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Apeloa Pharmaceutical Co Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥6.35 Billion
≈ $928.67 Million
CN¥1.23 Billion
≈ $180.09 Million
0.194x +8.29%
2024-12-31 CN¥6.75 Billion
≈ $987.72 Million
CN¥1.21 Billion
≈ $176.88 Million
0.179x +8.18%
2023-12-31 CN¥6.23 Billion
≈ $911.71 Million
CN¥1.03 Billion
≈ $150.92 Million
0.166x -31.10%
2022-12-31 CN¥5.52 Billion
≈ $807.64 Million
CN¥1.33 Billion
≈ $194.05 Million
0.240x +98.74%
2021-12-31 CN¥5.06 Billion
≈ $740.44 Million
CN¥611.75 Million
≈ $89.52 Million
0.121x -49.90%
2020-12-31 CN¥4.39 Billion
≈ $642.49 Million
CN¥1.06 Billion
≈ $155.04 Million
0.241x -33.15%
2019-12-31 CN¥3.77 Billion
≈ $551.37 Million
CN¥1.36 Billion
≈ $199.02 Million
0.361x +45.01%
2018-12-31 CN¥3.35 Billion
≈ $489.52 Million
CN¥832.69 Million
≈ $121.85 Million
0.249x +261.87%
2017-12-31 CN¥3.05 Billion
≈ $446.31 Million
CN¥209.80 Million
≈ $30.70 Million
0.069x -0.24%
2016-12-31 CN¥2.62 Billion
≈ $382.88 Million
CN¥180.42 Million
≈ $26.40 Million
0.069x -62.22%
2015-12-31 CN¥2.42 Billion
≈ $353.65 Million
CN¥441.16 Million
≈ $64.56 Million
0.183x -46.49%
2014-12-31 CN¥2.31 Billion
≈ $337.43 Million
CN¥786.64 Million
≈ $115.11 Million
0.341x +232.78%
2013-12-31 CN¥1.86 Billion
≈ $271.86 Million
CN¥190.45 Million
≈ $27.87 Million
0.103x -58.33%
2012-12-31 CN¥1.37 Billion
≈ $199.83 Million
CN¥335.90 Million
≈ $49.15 Million
0.246x -25.14%
2011-12-31 CN¥1.23 Billion
≈ $180.21 Million
CN¥404.62 Million
≈ $59.21 Million
0.329x +119.48%
2010-12-31 CN¥808.57 Million
≈ $118.32 Million
CN¥121.05 Million
≈ $17.71 Million
0.150x -42.88%
2009-12-31 CN¥794.78 Million
≈ $116.30 Million
CN¥208.30 Million
≈ $30.48 Million
0.262x +112.87%
2008-12-31 CN¥768.11 Million
≈ $112.40 Million
CN¥94.57 Million
≈ $13.84 Million
0.123x -46.98%
2007-12-31 CN¥750.11 Million
≈ $109.76 Million
CN¥174.20 Million
≈ $25.49 Million
0.232x -36.48%
2006-12-31 CN¥436.05 Million
≈ $63.81 Million
CN¥159.43 Million
≈ $23.33 Million
0.366x +72.33%
2005-12-31 CN¥411.93 Million
≈ $60.28 Million
CN¥87.40 Million
≈ $12.79 Million
0.212x +65.59%
2004-12-31 CN¥371.08 Million
≈ $54.30 Million
CN¥47.54 Million
≈ $6.96 Million
0.128x -60.01%
2003-12-31 CN¥328.83 Million
≈ $48.12 Million
CN¥105.36 Million
≈ $15.42 Million
0.320x +3243.46%
2002-12-31 CN¥293.69 Million
≈ $42.98 Million
CN¥2.81 Million
≈ $411.85K
0.010x +536.80%
2001-12-31 CN¥259.70 Million
≈ $38.00 Million
CN¥-569.79K
≈ $-83.38K
-0.002x -108.50%
2000-12-31 CN¥274.23 Million
≈ $40.13 Million
CN¥7.08 Million
≈ $1.04 Million
0.026x +138.74%
1999-12-31 CN¥307.93 Million
≈ $45.06 Million
CN¥-20.52 Million
≈ $-3.00 Million
-0.067x -150.12%
1998-12-31 CN¥226.31 Million
≈ $33.12 Million
CN¥30.10 Million
≈ $4.40 Million
0.133x --

About Apeloa Pharmaceutical Co Ltd

SHE:000739 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.77 Billion
CN¥18.96 Billion CNY
Market Cap Rank
#5267 Global
#1003 in China
Share Price
CN¥16.37
Change (1 day)
+0.49%
52-Week Range
CN¥13.85 - CN¥19.36
All Time High
CN¥39.53
About

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&… Read more